Avricore Health INC. (AVCRF) — 6-K Filings

All 6-K filings from Avricore Health INC.. Browse 13 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (13)

Avricore Health Inc. Files November 2025 6-K Report — Dec 10, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K on December 10, 2025, for the reporting period ending November 30, 2025. The company, formerly known as Vanc Pharmaceutica
Avricore Health Inc. Files August 2025 6-K Report — Sep 15, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K for the month of August 2025, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals I
Avricore Health Inc. Files July 2025 6-K Report — Aug 8, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K on August 8, 2025, for the month of July 2025. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceutic
Avricore Health Inc. Files June 2025 6-K Report — Jul 11, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K for the month of June 2025, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals Inc
Avricore Health Inc. Files May 2025 6-K Report — Jun 5, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K for the month of May 2025, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals Inc.
Avricore Health Inc. Files April 2025 6-K Report — May 20, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K on May 20, 2025, for the month of April 2025. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceutica
Avricore Health Inc. Files January 2025 6-K Report — Feb 6, 2025 Risk: low
Avricore Health Inc. filed a Form 6-K on February 6, 2025, for the month of January 2025. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmac
Avricore Health Inc. Files November 2024 6-K Report — Dec 5, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K for the month of November 2024, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals
Avricore Health Inc. Files September 2024 6-K Report — Oct 7, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K on October 7, 2024, for the month of September 2024. The company, formerly known as Vanc Pharmaceuticals Inc. and NUVA Pha
Avricore Health Inc. Files August 2024 6-K Report — Sep 6, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K on September 6, 2024, for the reporting period ending August 31, 2024. The company, formerly known as Vanc Pharmaceuticals
Avricore Health Inc. Files 6-K Report — Jul 9, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K on July 9, 2024, for the reporting period ending June 30, 2024. The company, formerly known as Vanc Pharmaceuticals Inc.,
Avricore Health Inc. Files May 2024 6-K Report — Jun 20, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K on June 20, 2024, for the month ending May 31, 2024. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharma
Avricore Health Inc. Files April 2024 6-K Report — May 8, 2024 Risk: low
Avricore Health Inc. filed a Form 6-K for the month of April 2024, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals In

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX